Business Wire

Rahi Systems Launches Cloud Strategy Headed by New CTO Matt Robinson

8.1.2020 19:00:00 EET | Business Wire | Press release

Share

Rahi Systems announced today the launch of its cloud strategy and the addition of Matt Robinson as CTO for cloud and infrastructure. Robinson will lead the development of Rahi’s cloud services, which will leverage Rahi’s proven ability to deliver cost-effective and efficient data center infrastructure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200108005141/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Cloud practices, professional services, and managed services will complement Rahi’s industry-leading expertise in data center infrastructure. (Graphic: Business Wire)

Today, every enterprise uses cloud services but few rely on the cloud exclusively. Many organizations need help developing a holistic approach across cloud and on-premises environments. The Rahi team can serve as that overlay, helping to align an organization’s cloud strategy with its data center strategy and implement the right mix of cloud services to meet business and IT requirements. Rahi also offers cloud managed services that fill skills gaps, ensure operational efficiency and optimize the cloud environment.

“Few IT solution providers offer cloud services, and most cloud companies must partner with VARs for on-premises solutions. Rahi can do both well,” said Tarun Raisoni, CEO & Co-Founder, Rahi Systems. “We are very excited to put a framework and methodology around our cloud strategy, and to have an industry veteran of Matt’s caliber heading up our cloud services.”

Robinson has been in the technology industry for the past 27 years, most recently as head of partner engineering at Google Cloud. He has previously held leadership roles at NetApp, Silicon Graphics and Alacritech across a variety of functions, including engineering, marketing, product management, professional services and customer support. “I’m delighted to be joining the Rahi family to help build a world-class cloud and infrastructure organization,” said Robinson. “Rahi’s longstanding data center and infrastructure experience at Fortune 500 clients helps set the stage for us to deliver hybrid and multi-cloud solutions across every industry vertical. With a strong focus on building a data strategy through strategic workload placement and strong governance models in cloud environments, Rahi will help its customers achieve their business goals faster and with more confidence.”

Learn more about Rahi’s cloud approach, methodology and service offerings by visiting Rahi Cloud Services.

About Rahi Systems

Rahi Systems delivers a suite of solutions and services that optimizes cost, performance, scalability, manageability and efficiency of today’s integrated environments. Founded in 2012 by entrepreneurs with deep understanding of the needs and challenges of service providers, government agencies and enterprises, the company has grown through a solutions-oriented approach, outstanding support and a culture of customer success. Rahi has its corporate headquarters in Fremont, Calif., with offices in the U.S., India, Hong Kong, Singapore, China, Taiwan, Turkey, Ireland, France, Germany, the Netherlands, the United Kingdom, Japan, South Korea, Malaysia, the Philippines, Indonesia, and Australia.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Alison Lolis
VP of Marketing
+1 510.651.2205
alison@rahisystems.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 08:30:00 EET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe ® Launches LeukoStrat ® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 07:30:00 EET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 02:00:00 EET | Press release

VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise Reduction (CNR) and radial Lens Shading Correction (LSC), and featu

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye